Bitcoin to FAANG (Facebook, Apple, Amazon, Netflix and Google) stocks, it’s become the talking heads’ favorite daytime activity to opine about their imminent collapse.
The Verge just published a fascinating survey. It indicates that consumers trust Amazon almost as much as their own bank. Google was a close second to Amazon in trustworthiness. Is this alarming or natural? Let’s break it down...
Whether we like it or not, millennials continue to help shape the economy. If you’re in denial of the power of millennials, consider this…
Google suddenly seems keen on saving the beleaguered newspaper industry. It’s reversing a decade-old policy that forces publishers to offer free web content in order to get primo search engine listings. Let’s unpack the timing of Google’s decision and then I’ll determine whether or not it’s worthy of an investment.
We’ve got two months of good data on the recently launched FAANG ETF (NYSE: FNG) — officially known as the AdvisorShares New Tech and Media ETF. To no one’s surprise, FNG has been besting the S&P 500 since the ETF launched on July 14. Will FNG’s blitzkrieg persist into the foreseeable future? I’ve got 415 billion reasons why the answer is an emphatic “YES!”
Innovation never disappoints. That was the battle cry upon which I started at Wall Street Daily 10 years ago at the top of the oil boom. I’m especially bullish on three specific industries at the moment.
A straight-up stock split is a purely bullish event, without exception. A reverse stock split, however, is done for a host of reasons — and not all of them are good. So with reverse stock splits currently exploding, we must sharpen our lens to understand the true nature of what’s happening. So I asked my senior analyst, Martin Hutchinson, to solve the stock-split conundrum for us.
From Lost in Space to Inspector Gadget, wearable technology has long since been a “thing of the future.” But that future is inching closer, as many tech companies are working to make it ubiquitous.
According to Lux Research, self-driving cars will represent an $87 billion opportunity by 2030. But it won’t happen without this critical technology.
The FDA just approved the world’s first artificial pancreas for the treatment of Type 1 diabetes. Here’s the company behind the innovation.